Anti-Human CIP2A Polyclonal Antibody
- Cat. No.：RB9THV712014
- Price：Negotiable
- Clicks：280
Product Detail
Product Parameters
| Form | Liquid |
|---|---|
| Host Species | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Purification | Purified by antigen affinity column. |
| Endotoxin Level | Please contact with the lab for this information. |
| Applications | ELISA, IHC, WB |
| Species Reactivity | Human |
| Target | CIP2A, Cancerous inhibitor of PP2A, KIAA1524, Protein CIP2A, p90 autoantigen |
| Immunogen | E. coli - derived recombinant Human CIP2A (Asp2-Glu560). |
| Storage Buffer | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| Product Usage Information | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| Accession Number | Q8TCG1 |
| Background | Protein CIP2A is a ~102 kDa protein. Acts as an inhibitor of protein phosphatase PP2A. Promotes anchorage-independent cell growth and tumor formation by preventing dephosphorylation of MYC, thereby stabilizing MYC in human malignancies. Together with TOPBP1, plays an essential role in the response to genome instability generated by the presence of acentric chromosome fragments derived from shattered chromosomes within micronuclei. Micronuclei, which are frequently found in cancer cells, consist of chromatin surrounded by their own nuclear membrane: following breakdown of the micronuclear envelope, a process associated with chromothripsis, the CIP2A-TOPBP1 complex tethers chromosome fragments during mitosis to ensure clustered segregation of the fragments to a single daughter cell nucleus, facilitating re-ligation with limited chromosome scattering and loss. 1. Junttila, MR. et al. (2007) Cell 130, 51-62. PMID: 17632056 2. Adam, S. et al. (2021) Nature cancer 2, 1357-1371. PMID: 35121901 3. De Marco Zompit, M. et al. (2022) Nature communications 13, 4143. PMID: 35842428 4. Lin, YF. et al. (2023) Nature 618, 1041-1048. PMID: 37165191 5. Trivedi, P. et al. (2023) Nature 618, 1049-1056. PMID: 37316668 |
| Note | For research use only |
Related Products: